Sphera Funds Management Ltd. Zai Lab LTD Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $3.1 Million - $7.19 Million	-111,641 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$54.9 - $105.21 $1.89 Million - $3.61 Million	-34,341 Reduced 23.52%	111,641 $7.02 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $5.04 Million - $8.57 Million	48,036 Added 49.04%	145,982 $15.4 Million
Q2 2021 Aug 17, 2021	BUY	$125.11 - $180.0 $4.02 Million - $5.79 Million	32,158 Added 48.88%	97,946 $17.3 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $8.31 Million - $12.6 Million	65,788 New	65,788 $8.78 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.62B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.